Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
Cell line generation
CARDIAC SAFETY SCREENING SERVICES
Cardiac safety screening
New Approach Methodologies
hERG screening
Clinically translatable hiPSC cardiomyocyte assays
hiPSC-derived cardiomyocyte screening
Chronic cardiotoxicity screening using hiPSC-derived cardiomyocytes
CiPA screening services
NEUROSCIENCE SERVICES
Neuroscience services
Brain slice electrophysiology services for CNS drug discovery
Native neuronal ion channel assays
Central Neuronal Firing
Pain research
Neuroscience translational assays
INTEGRATED SERVICES
Integrated drug discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Testimonials
Leadership
Board
Senior Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
Cell line generation
CARDIAC SAFETY SCREENING SERVICES
Cardiac safety screening
New Approach Methodologies
hERG screening
Clinically translatable hiPSC cardiomyocyte assays
hiPSC-derived cardiomyocyte screening
Chronic cardiotoxicity screening using hiPSC-derived cardiomyocytes
CiPA screening services
NEUROSCIENCE SERVICES
Neuroscience services
Brain slice electrophysiology services for CNS drug discovery
Native neuronal ion channel assays
Central Neuronal Firing
Pain research
Neuroscience translational assays
INTEGRATED SERVICES
Integrated drug discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Testimonials
Leadership
Board
Senior Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Home
>
Events
>
In Vitro Assessment of Cardiac Risk in Drug Discovery
In Vitro Assessment of Cardiac Risk in Drug Discovery
Dates & Times
May 16th 2024
Ion channel, cardiac safety and neuroscience news
Subscribe to our newsletter
Let’s work together
Contact us for a quote or discussion
Search metrionbiosciences.com
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
About Metrion
Metrion is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Visit our Facebook
Visit our LinkedIn
Visit our YouTube channel
Links
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Integrated Drug Discovery
Our Approach
Knowledge Library
News & Events
Contact
SUBSCRIBE TO NEWSLETTER
Copyright © 2024 Metrion. All rights reserved |
Privacy notice
| Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
Cookie Settings
magnifier
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
